Skip to content
10-Q

Quarterly Report

MEDICIS PHARMACEUTICAL CORP

0001193125-12-461078

← back to feed
Filed
Nov 9, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2012 · Sep 30, 2012 58.33M sh
Shares Diluted Q3 2012 · Sep 30, 2012 63.67M sh
Shares Diluted Q3 2012 · Sep 30, 2011 67.91M sh
Shares Diluted Q3 2012 · Sep 30, 2011 66.96M sh
Stock Repurchased Q3 2012 · Sep 30, 2012 $49.91M
Stock Repurchased Q3 2012 · Sep 30, 2011 $1.78M
Dividends Paid Q3 2012 · Sep 30, 2012 $16.56M
Dividends Paid Q3 2012 · Sep 30, 2011 $13.57M
Capex Q3 2012 · Sep 30, 2012 $12.76M
Capex Q3 2012 · Sep 30, 2011 $4.23M
Operating Cash Flow Q3 2012 · Sep 30, 2012 $76.9M
Operating Cash Flow Q3 2012 · Sep 30, 2011 $136.74M
Short Term Investments Q3 2012 · Sep 30, 2012 $629.81M
Short Term Investments Q3 2012 · Dec 31, 2011 $245.5M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $130.12M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $42.82M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $184.05M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $218.36M
Stockholders Equity Q3 2012 · Sep 30, 2012 $827.83M
Stockholders Equity Q3 2012 · Dec 31, 2011 $831.98M
Current Liabilities Q3 2012 · Sep 30, 2012 $391M
Current Liabilities Q3 2012 · Dec 31, 2011 $574.8M
Current Assets Q3 2012 · Sep 30, 2012 $1.07B
Current Assets Q3 2012 · Dec 31, 2011 $551.15M
Total Assets Q3 2012 · Sep 30, 2012 $1.86B
Total Assets Q3 2012 · Dec 31, 2011 $1.45B
Eps Diluted Q3 2012 · Sep 30, 2012 $0.02
Eps Diluted Q3 2012 · Sep 30, 2012 $0.36
Eps Diluted Q3 2012 · Sep 30, 2011 $0.29
Eps Diluted Q3 2012 · Sep 30, 2011 $1.01
Eps Basic Q3 2012 · Sep 30, 2012 $0.02
Eps Basic Q3 2012 · Sep 30, 2012 $0.36
Eps Basic Q3 2012 · Sep 30, 2011 $0.31
Eps Basic Q3 2012 · Sep 30, 2011 $1.09
Sga Expense Q3 2012 · Sep 30, 2012 $111.49M
Sga Expense Q3 2012 · Sep 30, 2012 $316.86M
Sga Expense Q3 2012 · Sep 30, 2011 $93.23M
Sga Expense Q3 2012 · Sep 30, 2011 $268.25M
Rd Expense Q3 2012 · Sep 30, 2012 $12.26M
Rd Expense Q3 2012 · Sep 30, 2012 $87.41M
Rd Expense Q3 2012 · Sep 30, 2011 $28.73M
Rd Expense Q3 2012 · Sep 30, 2011 $58.2M
Net Income Q3 2012 · Sep 30, 2012 $937K
Net Income Q3 2012 · Sep 30, 2012 $21.21M
Net Income Q3 2012 · Sep 30, 2011 $19.45M
Net Income Q3 2012 · Sep 30, 2011 $67.6M
Operating Income Q3 2012 · Sep 30, 2012 $15.78M
Operating Income Q3 2012 · Sep 30, 2012 $54.7M
Operating Income Q3 2012 · Sep 30, 2011 $36.03M
Operating Income Q3 2012 · Sep 30, 2011 $140.27M
Gross Profit Q3 2012 · Sep 30, 2012 $160.59M
Gross Profit Q3 2012 · Sep 30, 2012 $516.19M
Gross Profit Q3 2012 · Sep 30, 2011 $167.5M
Gross Profit Q3 2012 · Sep 30, 2011 $490.67M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $19.6M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $62.3M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $17.17M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $49.74M
Revenue Q3 2012 · Sep 30, 2012 $180.2M
Revenue Q3 2012 · Sep 30, 2012 $578.49M
Revenue Q3 2012 · Sep 30, 2011 $184.67M
Revenue Q3 2012 · Sep 30, 2011 $540.41M